- Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, et al. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation. 2013;127(14):1493-502.
- Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137-49.
- Huldani H, Jasim SA, Bokov DO, Abdelbasset WK, Shalaby MN, Thangavelu L, et al. Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases. Int Immunopharmacol. 2022;106:108634.
- Karki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genom. 2015;8(1):1-7.
- Teama S. DNA polymorphisms: DNA-based molecular markers and their application in medicine. Genetic Diversity and Disease Susceptibility. 2018;25.
- Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81.
- Leslie RD, Palmer J, Schloot NC, Lernmark A. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia. 2016;59(1):13-20.
- Yang M, Zhao J, Xing L, Shi L. The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients. J Renin Angiotensin Aldosterone Syst. 2015;16(4):1240-4.
- Benjafield AV, Wang WY, Morris BJ. No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens. 2004;17(7):624-8.
- Huang W, Yang W, Wang Y, Zhao Q, Gu D, Chen R. Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese. J Hum Hypertens. 2006;20(12):968-71.
- Doris PA. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension. 2002;39(2):323-31.
- Alghamri MS, Weir NM, Anstadt MP, Elased KM, Gurley SB, Morris M. Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice. J Cardiovasc Pharmacol. 2013;18(2):138-51.
- Olegovich Bokov D, Jalil AT, Alsultany FH, Mahmoud MZ, Suksatan W, Chupradit S, et al. Ir-decorated gallium nitride nanotubes as a chemical sensor for recognition of mesalamine drug: a DFT study. Mol Simul. 2022:1-10.
- Zhou J-B, Yang J-K. Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 2009;10(1):31-4.
- Elihimas Júnior UF, Elihimas HCdS, Lemos VM, Leão MdA, Sá MPBdO, França EETd, et al. Smoking as risk factor for chronic kidney disease: systematic review. J Bras Nefrol. 2014;36:519-28.
- Zhang Y, Jia N, Hu F, Fan N, Guo X, Du H, et al. Association of single-nucleotide polymorphisms in the RAGE gene and its gene-environment interactions with diabetic nephropathy in Chinese patients with type 2 diabetes. Oncotarget. 2017;8(57):96885.
- Cai W, Li J, Xu J-X, Liu Y, Zhang W, Xiao J-R, et al. Association of 2184AG polymorphism in the RAGE gene with diabetic nephropathy in Chinese patients with type 2 diabetes. J Diabetes Res. 2015;2015.
- Ansari MJ, Jasim SA, Taban TZ, Bokov DO, Shalaby MN, Al-Gazally ME, et al. Anticancer drug-loading capacity of green synthesized porous magnetic iron nanocarrier and cytotoxic effects against human cancer cell line. J Clust Sci. 2022:1-11.
- Elsheikh M, Casadei B, Conway G, Wass J. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol. 2001;54(1):69-73.
- Liu C, Li Y, Guan T, Lai Y, Shen Y, Zeyaweiding A, et al. ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):1-11.
|